Jakafi 5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FSQP6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,793
Award facts
- Contract value 100% obligated
- $24,793.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24,793.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). The contract is firm fixed-price with no set-aside designation and has an ultimate completion date of December 17, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors to support Department of Defense pharmaceutical supply needs globally.
DMS Pharmaceutical Group's PPV-G GEN V parent contract, awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, encompassing a 30-month base period with three 30-month option periods. The company supplies an extensive portfolio of pharmaceuticals including branded and generic prescription medications, biologics, vaccines, and medical consumables to military healthcare facilities worldwide. As a single-award IDC holder, DMS Pharmaceutical Group has demonstrated substantial performance through numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division, positioning the company as a critical supplier within the federal pharmaceutical distribution network for Department of Defense operations.
Quick answers
Who was awarded contract SPE2DR26FSQP6?
SPE2DR26FSQP6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FSQP6 worth?
The government has obligated $24,793 on SPE2DR26FSQP6.
Is contract SPE2DR26FSQP6 an order under another contract?
Yes. SPE2DR26FSQP6 is a delivery order under SPE2DR25D9348, an indefinite delivery contract.
Was contract SPE2DR26FSQP6 competed?
The extent of competition for SPE2DR26FSQP6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award